Harvey Black | Aug 17, 1997 | 8 min read
Multiple sclerosis (MS) continues to baffle those who seek to understand it. The cause of the disease remains obscure, as does the mechanism of the drugs used to ameliorate its symptoms. Affecting 0.1 percent of the population, the neurodegenerative disease is marked by demyelination, or the destruction of the myelin sheath on neurons in the brain and spinal cord. Researchers have been scrutinizing the proteins and lipids composing myelin, studying genetics of patients, exploring links between